JUVEDERM HYALURONATE GEL IMPLANTS
FDA premarket approval P050047/S033 · decided 2014-04-17
Approval details
- PMA number
- P050047
- Supplement
- S033
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- JUVEDERM HYALURONATE GEL IMPLANTS
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Allergan
- Date received
- 2013-12-04
- Decision date
- 2014-04-17
- Days to decision
- 134 days
- Decision code
- APPR
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Irvine, CA
- Statement
- APPROVAL FOR A CHANGE TO THE QUALITY CONTROL TESTING METHOD USED TO CONFIRM THE CONCENTRATION OF LIDOCAINE AND LIDOCAINE DEGREDANTS IN JUVÉDERM HYALURONATE GEL IMPLANTS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229) | Allergan | 2021-06-02 |
| TrueTear Intranasal Tear Neurostimulator (K193589) | Allergan | 2020-08-31 |
| Natrelle 133 Plus MICROCELL Tissue Expander (K180826) | Allergan | 2018-12-21 |
| Natrelle 133S Tissue Expander (K182054) | Allergan | 2018-08-29 |
| TrueTear Intranasal Tear Neurostimulator (DEN170086) | Allergan | 2018-05-17 |
| SERI SURGICAL SCAFFOLD (K123128) | Allergan | 2013-04-25 |